Schneid Yair 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-26 4:45 pm Sale | 2024-09-23 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 374 8.374% | -50 (-11.84%) | Filing |
| 2024-01-16 6:07 pm Purchase | 2024-01-05 | 13G | ReShape Lifesciences Inc. RSLS | Schneid Yair | 424 10.525% | 424 (New Position) | Filing |